📌 Key Takeaways
- Topic: What Is Pyrogenic Silica? How It Is Made and Why It Is Used as a Thickener
- Keywords: tridymite
- Published: 2026-11-20 00:39:04
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for Floor Coatings: Anti-Slip, Matting and Rheology Functions
- What Is Highly Dispersible Silica (HDS)? Benefits for Tire Performance Explained
- 2.1. Particle Size
- What Is Precipitated Silica? Production Process, Properties and Main Applications
- Nevertheless, mesoporous carriers are frequently associated with poor tabletability because of bad powder flow behavior; thus, direct tableting can only be attained by adding diverse excipients in large quantities [ 95 ]. Such useful excipients include microcrystalline cellulose (filler), lactose monohydrate (filler), PVP (binder), sodium carboxymethylcellulose (disintegrant), croscarmellose sodium (super disintegrant), colloidal silica (anti-adhesion material), magnesium stearate (lubricant), and talc (lubricant) [ 39, 95, 96, 97 ]. However, the drug content in the dosage unit decreases with high amounts of excipients added, so larger tablets must be designed to attain the proper dose [ 95 ]. Another issue is that the greater compression force used during tableting may deform and damage the pore structure of the carrier, which might decrease the expected drug release rate [ 36, 97, 98 ]. When higher compression forces are applied, the pore diameter decreases, which affects both total pore volume and particular surface region, reducing the drug release rate from the carrier [ 97, 98 ]. The use of microcrystalline cellulose may be a solution to this problem, as it deforms plastically under pressure while distributing the energy accumulated in the tablet during compression. Furthermore, croscarmellose sodium may improve the drug release rate [ 97, 98 ]. Granulation of mesoporous material is a proper choice to solve issues related to poor powder rheology.
- Silica as a Thickening Agent: How It Works in Liquids, Resins and Gels
- Being 100% chemical-free, you don't have to worry about it harming children or animals
- Silica Supplier UAE: How to Source Silica for the UAE and GCC Markets
How to Choose a Silica Supplier: Key Criteria, Certifications and Red Flags
What is silica (SiO₂)?
What is the difference between fumed silica and precipitated silica?
how is silica made
What drives silica raw material prices?
Evonik Aerosil Even though MSNs can usually be recognized as secure products, their use during therapy may cause side impacts in the body [ 1, 2, 29 ]. Due to their small size and large surface area, they may tend to accumulate in the body, or certain organs (liver, spleen, kidney, lung) and may even be toxic in higher concentrations, which is a clear disadvantage [ 1, 4, 27 ]. The silanol groups (Si-OH) on their surface can interact with the phospholipid layer of the cell membrane, thereby causing cell lysis or, in extreme cases, hemolysis [ 4, 8 ]. In severe cases, the lack of hemocompatibility can also cause issues [ 2 ]. Overall, indications of cytotoxicity, haemotoxicity, and genotoxicity were also found [ 4, 8 ]. That is why the biocompatibility of all comparable preparations must be strictly controlled [ 2, 4, 27 ]. The physicochemical features (particle size, particle morphology, surface chemistry, pore structure, etc.) of nanocarriers also have a major impact on toxicity [ 2, 4, 8, 30 ]. Additionally, further attention must be paid to the biological influences of their decomposition products, because they may also cause unwanted side influences [ 1 ]. The breakdown of silica nanoparticles in the body can take up to a few days. The opening hydration is followed by hydrolysis, and, in the end, they are excreted in the urine in the form of silicic acid [ 1 ]. Nevertheless, the literature is contradictory in this regard [ 31 ]. Some experiments show no considerable cytotoxic effect [ 18, 31 ], while other experiments say otherwise [ 23, 32 ]. For example, an in vitro study was performed with multiple concentrations, surfaces, and particle sizes (60 nm, 100 nm, 300 nm) of MSNs, with an exposure time of 72 h [ 18 ]. This study shown no significant cytotoxic influence in any of the cell lines tested (human cervical (HeLA), epithelial lung (A549), and glioblastoma (U251)) [ 18 ]. Ismail et al. investigated the cytotoxic effect of silica nanoparticles in vivo in mouse models [ 33 ]. Amorphous silica nanoparticles were administered to the animals orally, at a dose of 150 mg/kg/day, for 3 months. Based on these mouse models, no toxic effects were detected under sub-chronic treatment of the nanoparticles [ 31 ]. In another study, particle size (15 nm, 60 nm, 200 nm) dependent impact was observed on cellular viability in all four cell lines tested (THP-1 derived macrophages, A549 epithelial cells, HaCaT keratinocytes, and NRK-52E kidney cells) [ 23 ]. Smaller particles caused notable toxicity on each cell line, after the exposure time of 24 h, in contrast to the larger particles, which demonstrated no cytotoxic impact [ 23 ]. A comparable outcome has been published to verify the toxic characteristic of mesoporous silica. In this in vitro study, the researchers investigated the effect of MSNs with an average size of 7 nm on cell viability at three different concentrations. After 72 h of exposure, only the highest concentration (62.5 µg/mL) caused a substantial decrease in cell viability of human lung fibroblast cells. This toxicity occurred in a time- and dose-dependent manner [ 32 ]. In an in vivo mouse model, MacCuaig et al. presented coating-dependent impacts after repeated intravenous administration of MSNs. Chitosan-coated MSNs induced minor organ changes and were the most biocompatible. Uncoated and especially PEG-coated MSNs (especially 2K PEG) moderately augmented pre-existing vascular or organ lesions, implying that PEGylation has the potential to augment chronic risks, while chitosan enables safer long-term use [ 34 ]. An in vitro study of Barguilla et al. exposed epithelial lung cells to bare, PEG-functionalized, or galacto-oligosaccharide-functionalized MSNs for eight weeks. There was no reported long-term DNA damage, but malignant-like alterations like anchorage-independent growth, boosted migration/invasion, and secretome-facilitated tumor promotion were triggered by PEG- and GAL-functionalized MSNs. Naked MSNs did not cause such alterations and were determined to be safer [ 35 ]. Coating, on the whole, exerts a significant impact on the safety of MSNs. Uncoated MSNs are relatively innocuous; the most biocompatible coatings were achieved with chitosan, but PEG and carbohydrate functionalization can be dangerous in the long run, from vascular toxicity in vivo to tumor-promoting activity in vitro [ 34, 35 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.